|
What makes the NeuroMove NM900™ a unique tool for Stroke Rehabilitation? |
| Q: Is this like regular
muscle stimulation?
No - the stimulation is only applied when
the patient
produces a real attempt to move the muscle and only then the
stimulation is applied for typically five seconds. There is no muscle
training involved with this short stimulation applied for 30 minutes, as
it is merely a replacement for any other reward such as giving the patient
a piece of candy or a sound, etc. It is found to be the most effective
feedback, since the patient can see that he/she can actually make a
difference and move the muscle - just by thinking about it. Some patients
also benefit from the sensory feedback in addition to the visual. No - Regular surface EMG (electromyography) may in some cases
also have a very sensitive input, but for most other applications the
input signals are filtered and averaged (RMS so that the small changes do
not affect a steady and clear reading for monitoring). For stroke
survivors — some have nearly no EMG activity or a lot of muscle tone with
high background "noise" — regular EMG/biofeedback will not
easily detect the changes that indicate a real attempt from the
brain. The NeuroMove measures peak values in the EMG and has a very fast
input circuitry. Instead of averaging the input, it does the opposite —
looks for a pattern in the small changes that indicate a real attempt.
A very effective demonstration of this is when a non-patient actually
triggers the Neuro-Move just by thinking about it and imagining a movement
of the limb. No - The procedure for each 30 minute session is:
Q: What does the FDA say? The NeuroMove was listed in 2001 and is the only device that has
"Stroke Rehabilitation" as an Indication for use. It is
listed by Health Canada and has CSA approval. |